[Granulomatous prostatitis as collateral effect of intravesical immunotherapy with BCG].
Twenty-five male patients with superficial bladder cancer underwent intravesical Bacillus Calmette Guerin immunotherapy. A high incidence of side effects has occurred using three different substrains of BCG. Our interest has been focused on BCG related granulomatous prostatitis: we have found four asymptomatic patients with histologically diagnosed disease. We suppose therefore that its incidence is underestimated.
Mattei
F M
FM
Istituto di Anatomia e Istologia Patologica, Università degli Studi di Siena.
Giovannelli
V
V
Schepis
L
L
Del Vecchio
M T
MT
Di Renzo
M
M
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D001500:BCG Vaccine / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D006099:Granuloma / Q000209:etiology*; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine
Prostatite granulomatosa come effetto collaterale dell'immunoterapia endovescicale con BCG.